Raymond James analyst Joseph Altobello maintained a Hold rating on Prestige Brand Holdings (PBH) today. The company’s shares closed last Thursday at $33.68.
According to TipRanks.com, Altobello is a 5-star analyst with an average return of 9.8% and a 62.6% success rate. Altobello covers the Consumer Goods sector, focusing on stocks such as The Estée Lauder Companies, MasterCraft Boat Holdings, and Harley-Davidson.
Currently, the analyst consensus on Prestige Brand Holdings is a Hold with an average price target of $45.00, a 30.1% upside from current levels. In a report released today, Oppenheimer also maintained a Hold rating on the stock.
See today’s analyst top recommended stocks >>
Based on Prestige Brand Holdings’ latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of $229 million and net profit of $43.71 million. In comparison, last year the company earned revenue of $232 million and had a net profit of $33.93 million.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. It operates through the following segments: North American OTC Healthcare, and International OTC Healthcare. The North American and International OTC Healthcare segments manages the following brands: BC/Goody’s, Beano, Boudreaux’s Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Efferdent, Fess, Fleet, Gaviscon, Hydralyte, Luden’s, Monistat, Nix, Pedia-Lax, and Summer’s Eve. The company was founded in 1996 and is headquartered in Tarrytown, NY.
